These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 11398114)

  • 1. CCR5 promoter polymorphisms in a Kenyan perinatal human immunodeficiency virus type 1 cohort: association with increased 2-year maternal mortality.
    John GC; Bird T; Overbaugh J; Nduati R; Mbori-Ngacha D; Rostron T; Dong T; Kostrikis L; Richardson B; Rowland-Jones SL
    J Infect Dis; 2001 Jul; 184(1):89-92. PubMed ID: 11398114
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Polymorphisms in the CCR5 promoter region influence disease progression in perinatally human immunodeficiency virus type 1-infected children.
    Ometto L; Bertorelle R; Mainardi M; Zanchetta M; Tognazzo S; Rampon O; Ruga E; Chieco-Bianchi L; De Rossi A
    J Infect Dis; 2001 Mar; 183(5):814-8. PubMed ID: 11181160
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A polymorphism in the regulatory region of the CC-chemokine receptor 5 gene influences perinatal transmission of human immunodeficiency virus type 1 to African-American infants.
    Kostrikis LG; Neumann AU; Thomson B; Korber BT; McHardy P; Karanicolas R; Deutsch L; Huang Y; Lew JF; McIntosh K; Pollack H; Borkowsky W; Spiegel HM; Palumbo P; Oleske J; Bardeguez A; Luzuriaga K; Sullivan J; Wolinsky SM; Koup RA; Ho DD; Moore JP
    J Virol; 1999 Dec; 73(12):10264-71. PubMed ID: 10559343
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CCR5 chemokine receptor variant in HIV-1 mother-to-child transmission and disease progression in children. French Pediatric HIV Infection Study Group.
    Misrahi M; Teglas JP; N'Go N; Burgard M; Mayaux MJ; Rouzioux C; Delfraissy JF; Blanche S
    JAMA; 1998 Jan; 279(4):277-80. PubMed ID: 9450710
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Heterozygosity for a defective gene for CC chemokine receptor 5 is not the sole determinant for the immunologic and virologic phenotype of HIV-infected long-term nonprogressors.
    Cohen OJ; Vaccarezza M; Lam GK; Baird BF; Wildt K; Murphy PM; Zimmerman PA; Nutman TB; Fox CH; Hoover S; Adelsberger J; Baseler M; Arthos J; Davey RT; Dewar RL; Metcalf J; Schwartzentruber DJ; Orenstein JM; Buchbinder S; Saah AJ; Detels R; Phair J; Rinaldo C; Margolick JB; Pantaleo G; Fauci AS
    J Clin Invest; 1997 Sep; 100(6):1581-9. PubMed ID: 9294127
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of natural chemokine receptor polymorphisms on perinatal transmission of human immunodeficiency virus type 1.
    Kostrikis LG
    Teratology; 2000 May; 61(5):387-90. PubMed ID: 10777836
    [No Abstract]   [Full Text] [Related]  

  • 7. Effects of polymorphisms of chemokine receptors on neurodevelopment and the onset of encephalopathy in children with perinatal HIV-1 infection.
    Llorente A; Brouwers P; Thompson B; Cheng I; Macmillan C; Larussa P; Mofenson L; Blasini I; Chase C
    Appl Neuropsychol; 2006; 13(3):180-9. PubMed ID: 17361671
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Host genetic background at CCR5 chemokine receptor and vitamin D receptor loci and human immunodeficiency virus (HIV) type 1 disease progression among HIV-seropositive injection drug users.
    Barber Y; Rubio C; Fernández E; Rubio M; Fibla J
    J Infect Dis; 2001 Nov; 184(10):1279-88. PubMed ID: 11679916
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of CCR2 chemokine receptor polymorphism on HIV type 1 mother-to-child transmission and child survival in Western Kenya.
    Brouwer KC; Yang C; Parekh S; Mirel LB; Shi YP; Otieno J; Lal AA; Lal RB
    AIDS Res Hum Retroviruses; 2005 May; 21(5):358-62. PubMed ID: 15929697
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of CCR5-Δ32 mutation among individuals with high risk behaviors, neonates born to HIV-1 infected mothers, HIV-1 infected individuals, and healthy people in an Iranian population.
    Donyavi T; Bokharaei-Salim F; Nahand JS; Garshasbi S; Esghaei M; Sadeghi M; Jamshidi S; Khanaliha K
    J Med Virol; 2020 Aug; 92(8):1158-1164. PubMed ID: 31854469
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of heterozygosity for the chemokine receptor CCR5 32-bp-deleted allele on plasma virus load and CD4 T lymphocytes in perinatally human immunodeficiency virus-infected children at 8 years of age.
    Buseyne F; Janvier G; Teglas JP; Ivanoff S; Burgard M; Bui E; Mayaux MJ; Blanche S; Rouzioux C; Rivière Y
    J Infect Dis; 1998 Oct; 178(4):1019-23. PubMed ID: 9806029
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CCR5, RANTES and SDF-1 polymorphisms and mother-to-child HIV-1 transmission.
    Katz DA; John-Stewart GC; Richardson BA; Majiwa M; Mabuka JM; Lohman-Payne B; Farquhar C
    Int J Immunogenet; 2010 Aug; 37(4):301-5. PubMed ID: 20518834
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CC chemokine receptor 5 genotype and susceptibility to transmission of human immunodeficiency virus type 1 in women.
    Philpott S; Weiser B; Tarwater P; Vermund SH; Kleeberger CA; Gange SJ; Anastos K; Cohen M; Greenblatt RM; Kovacs A; Minkoff H; Young MA; Miotti P; Dupuis M; Chen CH; Burger H
    J Infect Dis; 2003 Feb; 187(4):569-75. PubMed ID: 12599073
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Maternal SDF1 3'A polymorphism is associated with increased perinatal human immunodeficiency virus type 1 transmission.
    John GC; Rousseau C; Dong T; Rowland-Jones S; Nduati R; Mbori-Ngacha D; Rostron T; Kreiss JK; Richardson BA; Overbaugh J
    J Virol; 2000 Jun; 74(12):5736-9. PubMed ID: 10823884
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CCR5 promoter polymorphisms and HIV-1 perinatal transmission in Brazilian children.
    de Souza PR; Arraes LC; de Lima Filho JL; Bruneska D; Milanese M; Crovella S
    J Reprod Immunol; 2006 Feb; 69(1):77-84. PubMed ID: 16233918
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The coreceptor mutation CCR5Delta32 influences the dynamics of HIV epidemics and is selected for by HIV.
    Sullivan AD; Wigginton J; Kirschner D
    Proc Natl Acad Sci U S A; 2001 Aug; 98(18):10214-9. PubMed ID: 11517319
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of CCR5-delta32 heterozygosity on the risk of perinatal HIV-1 infection: a meta-analysis.
    Contopoulos-Ioannidis DG; O'Brien TR; Goedert JJ; Rosenberg PS; Ioannidis JP
    J Acquir Immune Defic Syndr; 2003 Jan; 32(1):70-6. PubMed ID: 12514416
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Limited protective effect of the CCR5Delta32/CCR5Delta32 genotype on human immunodeficiency virus infection incidence in a cohort of patients with hemophilia and selection for genotypic X4 virus.
    Iversen AK; Christiansen CB; Attermann J; Eugen-Olsen J; Schulman S; Berntorp E; Ingerslev J; Fugger L; Scheibel E; Tengborn L; Gerstoft J; Dickmeiss E; Svejgaard A; Skinhøj P
    J Infect Dis; 2003 Jan; 187(2):215-25. PubMed ID: 12552446
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Decreased susceptibility of peripheral blood mononuclear cells from individuals heterozygous for a mutant CCR5 allele to HIV infection.
    Kim A; Pettoello-Mantovani M; Goldstein H
    J Acquir Immune Defic Syndr Hum Retrovirol; 1998 Oct; 19(2):145-9. PubMed ID: 9768623
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetic polymorphism of CCR5 gene and HIV disease: the heterozygous (CCR5/delta ccr5) genotype is neither essential nor sufficient for protection against disease progression. Swiss HIV Cohort.
    Morawetz RA; Rizzardi GP; Glauser D; Rutschmann O; Hirschel B; Perrin L; Opravil M; Flepp M; von Overbeck J; Glauser MP; Ghezzi S; Vicenzi E; Poli G; Lazzarin A; Pantaleo G
    Eur J Immunol; 1997 Dec; 27(12):3223-7. PubMed ID: 9464809
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.